news

New publication on Synoxyl® HSS (INCI: Trimethoxybenzylidene Pentanedione)

In a recent issue of the peer-reviewed journal, International Journal of Cosmetic Science, the authors reported the findings of a study conducted with Synoxyl® HSS. Results of this study shows that Synoxyl® HSS is an excellent photostabilizer of Avobenzone in sunscreen formulations and the performance is at least equal if not better than the currently available photostabilizers and also provides a 50% in-vivo SPF boosting. The ability of Synoxyl® HSS to stabilize avobenzone under ultraviolet (UV) light exposure was shown both in formulated products and in solution. A comparative stability study incorporating various combinations of avobenzone, Synoxyl® HSS (vs. three commercial photostabilizers) and UVB sunscreens clearly showed Synoxyl® HSS to be a very effective stabilizer. The photostabilizing effect of Synoxyl® HSS arises from triplet-state energy transfer from avobenzone to Synoxyl® HSS and through light-induced reactions that preserve the main chromophores. Interestingly, a 50% in vivo SPF boosting was observed when Synoxyl® HSS was used with organic and inorganic sunscreens when alone it has no contribution to SPF. Synoxyl® HSS-containing sunscreen formulations clearly showed a critical wavelength of well over 370 nm and can thus be categorized as broad-spectrum sunscreens. The optical properties of Synoxyl® HSS were estimated experimentally and supported by time-dependent density functional theory (TD-DFT) calculations.

For more information, please review or ask for a copy of this publication:

3-(3,4,5-Trimethoxybenzylidene)-2,4-pentanedione: Design of a novel photostabilizer with in vivo SPF boosting properties and its use in developing broad-spectrum sunscreen formulations, RK Chaudhuri, MA Ollengo, P Singh and BS Martincigh, Version of Record online: International J of Cosmetic Science, 29 JUN 2016 | DOI: 10.1111/ics.12344

Sytheon’s CEO to Speak at NYSCC Acne Care Symposium

Sytheon’s CEO to Speak at NYSCC Acne Care Symposium

Ratan K. Chaudhuri, Ph.D., President and CEO at Sytheon, will discuss key strategic targets for mitigating acne-affected skin. Sytheon, a...

by Drew FrantzenMay 19, 2023
Read More
Sytheon is excited to announce a publication on Synergistic…

Sytheon is excited to announce a publication on Synergistic…

Sytheon is excited to announce a publication on Synergistic Anti-Inflammatory Effects of Isosorbide Fatty Acid Diesters in Cytokine-Induced Tissue Culture...

by hostingagencyusDecember 6, 2022
Read More
Founder and CEO Dr. Ratan Chaudhuri has been named as a top 10…

Founder and CEO Dr. Ratan Chaudhuri has been named as a top 10…

Founder and CEO Dr. Ratan Chaudhuri has been named as a top 10 inspiring business leader by Inc. magazine to...

by hostingagencyusOctober 6, 2022
Read More
Sytenol® A is Accepted for Use in the Chinese Market

Sytenol® A is Accepted for Use in the Chinese Market

We are pleased to announce that Sytenol® A (Bakuchiol) has been successfully notified as a medium-low risk new cosmetic ingredient...

by hostingagencyusAugust 31, 2022
Read More
Sytheon Announces Relocation and Expansion of New Corporate Headquarters

Sytheon Announces Relocation and Expansion of New Corporate Headquarters

Sytheon relocates its headquarters to 10 Waterview Blvd, Parsippany, NJ. The move to a new state-of-the-art facility stems from Sytheon’s...

by hostingagencyusAugust 1, 2022
Read More
Bakuchiol – A natural alternative to Retinol shows holistic treatment approach…

Bakuchiol – A natural alternative to Retinol shows holistic treatment approach…

Bakuchiol – A natural alternative to Retinol shows holistic treatment approach for facial aging based on its multidirectional activity Beiersdorf...

by hostingagencyusJune 3, 2022
Read More